Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Japan
  4. Japan Exchange
  5. Asahi Intecc Co., Ltd.
  6. News
  7. Sector news
    7747   JP3110650003

ASAHI INTECC CO., LTD.

(7747)
  Report
Delayed Japan Exchange  -  01:00:00 2023-01-30 am EST
2290.00 JPY   -0.56%
01/16Asahi Intecc : Notice Regarding Absorption-type Merger of Consolidated Subsidiary(Simplified Merger / Short-form merger)
PU
2022Asahi Intecc : Notice Regarding to the English version of Asahi Intecc Group “Integrated Report 2022″
PU
2022Asahi Intecc to Acquire Manufacturer of Medical Instruments
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Sector news Medical Equipment
01/26Piper Sandler Adjusts ShockWave Medical's Price Target to $280 From $300, Keeps Overwei..
MT
01/26Insider Sell: Penumbra
MT
01/19NovoCure Appoints Chief Commercial Officer Pritesh Shah as Chief Growth Officer
MT
01/19Novocure Announces Executive Changes
CI
01/18Masimo, Philips Expand Technology Partnership
MT
01/18Masimo and Philips Expand Partnership to Improve Telehealth for Patients and Clinicians..
CI
01/17Top Midday Gainers
MT
01/17ShockWave Medical to Acquire Neovasc in Initial $100 Million Deal; Neovasc Shares Jump
MT
01/17Shockwave Medical In Agreement to Acquire Neovasc
MT
01/17Neovasc Inc., ShockWave Medical, Inc. - M&A Call
CI
01/17Piper Sandler Adjusts NovoCure's Price Target to $80 From $70, Maintains Neutral Rating
MT
01/17ShockWave Medical, Inc. Provides Earnings Guidance for the Fourth Quarter and Full Year..
CI
01/17Neovasc Brief: Shockwave Medical will acquire all outstanding Neovasc shar..
MT
01/17Neovasc Brief: Shockwave Medical Announcing Agreement to Acquire Neovasc
MT
01/17ShockWave Medical, Inc. (NasdaqGS:SWAV) entered into a..
CI
01/11Sector Update: Tech Stocks Advancing During Wednesday Trading
MT
01/11Sector Update: Tech Stocks Advancing Wednesday but Chipmakers Lag
MT
01/11Transcript : Masimo Corporation Presents at 41st Annual J.P. Morgan Healthcar..
CI
01/11Sector Update: Tech
MT
01/11Stifel Adjusts Price Target on Masimo to $170 From $164, Maintains Buy Rating
MT
01/11Masimo Says US Judge Ruled Apple Infringed Its Pulse Oximeter Patent
MT
01/11Sector Update: Health Care Stocks Flat to Higher Premarket Wednesday
MT
01/11Fresh Inflation Data Eyed as Exchange-Traded Funds, Equity Futures Rise Pre-Bell Wednes..
MT
01/11Masimo Says US Judge Ruled Apple Infringed Its Pulse Oximeter Patent
MT
01/11Insider Sell: Shockwave Medical
MT
01/10U.S. judge rules Apple Watches infringed Masimo patent - medical device maker
RE
01/10Transcript : NovoCure Limited Presents at 41st Annual J.P. Morgan Healthcare ..
CI
01/10Penumbra, Inc. Launches Latest Innovation in Mechanical Thrombectomy, Lightning Flash
CI
01/10Insider Sell: NovoCure
MT
01/10Insider Sell: NovoCure
MT
01/09NovoCure Reports Lower Q4, Higher 2022 Preliminary Revenue
MT
01/09Transcript : Penumbra, Inc. Presents at 41st Annual J.P. Morgan Healthcare Co..
CI
01/09NovoCure Reports Lower Q4, Higher 2022 Preliminary Revenue
MT
01/09Masimo Announces New Study Evaluates the Performance of Masimo Sphb Noninvasive Spot-Ch..
CI
01/06JPMorgan Adjusts NovoCure's Price Target to $99 From $86, Keeps Neutral Rating
MT
01/06Morgan Stanley Adjusts Price Target on ShockWave Medical to $224 From $290, Maintains E..
MT
01/06Wells Fargo Downgrades NovoCure to Equalweight From Overweight, Adjusts Price Target to..
MT
01/06Tumor Treating Fields Study by Zai Lab’s Partner in Cancer Patients Reaches Prima..
MT
01/05Sector Update: Health Care Stocks Nudge Above Thursday Intra-Day Lows
MT
01/05HC Wainwright Adjusts NovoCure's Price Target to $140 From $100, Maintains Buy Rating
MT
01/05Sector Update: Health Care Stocks Struggling Thursday but Biotech Edging H..
MT
01/05Top Midday Gainers
MT
01/05NovoCure, Zai Lab Study in Non-Small Cell Lung Cancer Meets Primary Endpoint'; Shares C..
MT
01/05Strong Labor Data in Spotlight After Hawkish Fed Minutes, US Equity Futures Turned Lowe..
MT
01/05NovoCure, Zai Lab Say Study of Non-Small Cell Lung Cancer Treatment Meets Primary Endpo..
MT
01/05Top Premarket Gainers
MT
01/05Zai Lab Limited and Novocure Announce Pivotal Lunar Study in Non-Small Cell Lung Cancer..
CI
01/05Novocure Announces Pivotal Lunar Study in Non-Small Cell Lung Cancer Met Primary Overal..
CI
01/05Masimo Patient SafetyNet™ Helped Clinicians Reduce CPR Events and Rates, Improve C..
CI
01/03Masimo Announces New Prospective Study Evaluates the Accuracy of Masimo SpHb« Noninvasi..
CI
2022Insider Sell: Shockwave Medical
MT
2022Truist Securities Adjusts Price Target on Penumbra to $255 From $228, Maintains Buy Rat..
MT
2022Medical device makers drop products as EU law sows chaos
RE
2022Deutsche Bank Initiates Coverage on ShockWave Medical With Buy Rating, $285 Price Targe..
MT
2022BTIG Upgrades Masimo to Buy From Neutral With $180 Price Target
MT
2022Masimo Issues Fiscal 2023 Outlook
MT
2022Transcript : Masimo Corporation - Analyst/Investor Day
CI
2022Masimo Announces Launch of the Expansion of the HEOS Platform to Provide Robust and Alw..
CI
2022ShockWave Medical Shares Drop After Wells Fargo Downgrade
MT
2022Wells Fargo Adjusts Penumbra Price Target to $255 From $225, Maintains Overweight Ratin..
MT
2022Citigroup Adjusts Price Target on Penumbra to $270 From $212, Maintains Buy Rating
MT
2022Wells Fargo Downgrades ShockWave Medical to Equalweight From Overweight, Lowers Price T..
MT
2022Masimo Corporation Announces Full Market Release of Hydration Index for the Masimo W1 A..
CI
2022Healthcare Company Getinge Signs Financing Partnership With BNP Paribas
MT
2022BTIG Ups Price Target on Penumbra to $240 From $204, Reiterates Buy Rating
MT
2022Needham Adjusts Masimo's Price Target to $173 From $149, Keeps Buy Rating
MT
2022Transcript : NovoCure Limited Presents at Piper Sandler 34th Annual Healthcar..
CI
2022Transcript : ShockWave Medical, Inc. Presents at Piper Sandler 34th Annual He..
CI
2022Transcript : Masimo Corporation Presents at Piper Sandler 34th Annual Healthc..
CI
2022NovoCure Secures Health Canada's Approval for Optune to Treat Newly Diagnosed and Recur..
MT
2022Wells Fargo Upgrades NovoCure to Overweight From Equalweight, Adjusts Price Target to $..
MT
2022Insider Sell: Shockwave Medical
MT
2022Transcript : Getinge AB - Special Call
CI
2022U.S. Food and Drug Administration Broadens the Consent Decree with Getinge and Includes..
CI
2022Peer-Reviewed Study Finds That Masimo Set« Pulse Oximetry Has No Clinically Significant..
CI
2022Law firm Sidley warns clients about rules that may hinder activists
RE
2022Masimo Shares Higher as Court Rules Former Executive Guilty of Stealing Trade Secrets
MT
2022Insider Sell: Shockwave Medical
MT
2022Insider Buy: Masimo
MT
2022Insider Buy: Masimo
MT
2022Transcript : Masimo Corporation Presents at Stifel 2022 Healthcare Conference..
CI
2022Penumbra, Inc. Launches First Hands-Free, Full Body Virtual Reality-Based Offering for ..
CI
2022Novocure Opens Office in Montreal to Expand and Support Growing Business in Canada
CI
2022Transcript : Penumbra, Inc. Presents at 13th Annual Jefferies London Healthca..
CI
2022Truist Securities Adjusts Penumbra Price Target to $228 From $200, Maintains Buy Rating
MT
2022RBC Boosts Price Target on Penumbra to $215 From $195, Likes Positioning Into 2023; Kee..
MT
2022NovoCure Says it Will Initiate Limited Market Release of Transducer Array in Europe Aft..
MT
2022Piper Sandler Lowers Price Target on Masimo to $135 From $150, Maintains Neutral Rating
MT
2022Tranche Update on Masimo Corporation's Equity Buyback Plan announced on August 9, 2022.
CI
2022Masimo Posts Higher Fiscal Q3 Adjusted EPS, Revenue; Issues Fiscal Q4, Narrows FY Guida..
MT
2022Transcript : Masimo Corporation, Q3 2022 Earnings Call, Nov 08, 2022
CI
2022GUIDANCE: (MASI) MASIMO Expects Q4 EPS Range $1.11 - $1.22
MT
2022GUIDANCE: (MASI) MASIMO Expects Q4 Revenue Range $581M - $611M
MT
2022Earnings Flash (MASI) MASIMO Reports Q3 Revenue $549.3M, vs. Street Est of $533.4M
MT
2022Earnings Flash (MASI) MASIMO Reports Q3 EPS $1.00, vs. Street Est of $0.92
MT
2022Masimo Corporation Provides Earnings Guidance for the Fourth Quarter and Full Year of 2..
CI
2022Masimo Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended..
CI
2022Wells Fargo Adjusts Price Target on ShockWave Medical to $300 From $255, Maintains Over..
MT
2022ShockWave Medical Earnings, Sales Increase in Q3; Lifts 2022 Revenue Guidance
MT
2022Transcript : ShockWave Medical, Inc., Q3 2022 Earnings Call, Nov 07, 2022
CI
Upcoming event on ASAHI INTECC CO., LTD.